| Authors: |
Bissonnette R; Innovaderm Research, Montreal, QC H2X 2V1, Canada. Electronic address: rbissonnette@innovaderm.com., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK., Pinter A; Department of Dermatology, Venereology, and Allergology, Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany., Agner T; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark., Gooderham M; Department of Medicine, Queens University, Kingston, ON, Canada., Schuttelaar MLA; University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Crépy MN; Department of Dermatology, University Hospital of Centre of Paris, Cochin Hospital, AP-HP, Paris, France., Stingeni L; Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Serra-Baldrich E; Department of Dermatology, Sant Pau Hospital, Barcelona, Spain., Baranowski K; LEO Pharma, Ballerup, Denmark., Korn S; LEO Pharma, Ballerup, Denmark., Kurvits M; LEO Pharma, Ballerup, Denmark., Plohberger U; LEO Pharma, Ballerup, Denmark., Strange Vest N; LEO Pharma, Ballerup, Denmark., Schliemann S; Department of Dermatology, University Hospital Jena, Jena, Germany. |
